Back to search

Article

Isomerization of antimalarial drug WR99210 explains its inactivity in a commercial stock

2020-07-01

Abstract excerpt

<h4>ABSTRACT</h4> WR99210, a former antimalarial drug candidate now widely used for the selection of Plasmodium transfectants, selectively targets the parasite dihydrofolate reductase thymidine synthase bifunctional enzyme (DHFR-TS) but not human DHFR, which is not fused with TS. Accordingly, WR99210 and plasmids expressing human dhfr have become valued tools for the genetic modification of parasites in the lab...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9860aebe-8f72-5578-8c01-5dc91d9e96e9
DOI
10.1101/2020.07.01.182402
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Isomerization of antimalarial drug WR99210 explains its inactivity in a commercial stockDOI 10.1101/2020.07.01.182402
Select a neighboring publication to make it the new centre.